Jay S. Stout, Chief Technology Officer at Immunovant, Inc. (IMVT), sold 10,008 shares at $12.99 ($130K) on 2025-04-09, disclosed to the SEC on 2025-04-11.
Open-market sale of $130k IMVT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.99 | 5,004 | $65K | 50.0% |
| 2 | $12.99 | 5,004 | $65K | 50.0% |
| Total | $12.99 avg | 10,008 | $130K | 100% |
| Filing → |
| IMVT | SELL | 2026-06-26 | $1.5M | — | Filing → |
| IMVT | SELL | 2026-04-24 | $82K | — | Filing → |
| IMVT | SELL | 2026-04-10 | $252K | — | Filing → |